Proteomic profiling of uremia in serum using magnetic bead-based sample fractionation and MALDI-TOF MS

Renal Failure

Volumn 32, Issue 10, 2010, Pages 1153-1159

  Sui, Weiguo ^a   Dai, Yong ^b   Zhang, Yue ^c   Chen, Jiejing ^a   Liu, Huaying ^c   Huang, He ^a  

^a Kidney Transplantation and Hemopurification Center of PLA   (China)

^b JINAN UNIVERSITY   (China)

^c GUANGXI NORMAL UNIVERSITY   (China)

Author keywords

ClinPro Tools; Magnetic bead; MALDI TOF MS; Serum peptide; Uremia

Indexed keywords

BIOLOGICAL MARKER; POLYPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ALGORITHM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDOMICS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SAMPLING; SERUM; STUDENT T TEST; UREMIA;

ADULT; AGED; CATION EXCHANGE RESINS; CHROMATOGRAPHY, ION EXCHANGE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UREMIA;

EID: 77958164420     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.517346     Document Type: Article

References (23)

1. Piorry PA, l'Heritier D. Traite des Alterations du Sang. Paris, France: Bury & JB Bailliere; 1840.
2. Langlois RG, Trebes JE, Dalmasso EA, et al. Serum protein profile alterations in hemodialysis patients. Am J Nephrol. 2004;24(2):268-274.
3. Wang J, Dai Y, Deng A, Liu J. Analysis of proteomic components of sera from patients with uremia by two dimensional electrophoresis and matrix assisted laser desorption/ionization time of flight mass spectrometry. J Huazhong Univ Sci Technolog Med Sci. 2005;25(5):604-607.
4. Lin WT, Tsai CC, Chen CY, et al. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis. Ren Fail. 2008;30(8):772-777.
5. Pandey A, Mann M. Proteomics to study genes and genomes. Nature. 2000;405(6788):837-846.
6. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11):845-867.
7. Thadikkaran L, Siegenthaler MA, Crettaz D, Queloz PA, Schneider P, Tissot JD. Recent advances in blood-related proteomics. Proteomics. 2005;5(12):3019-3034.
8. Koomen JM, Li D, Xiao LC, et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res. 2005;4(3):972-981.
9. Villanueva J, Philip J, Entenberg D, et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem. 2004;76(6):1560-1570.
10. Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W. Fishing for biomarkers: Analyzing mass spectrometry data with the new ClinProt Tools software. Biotechniques. 2005;38:37-40.
11. Vanholder R, De Smet R. Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol. 1999;10:1815-1823.
12. Thongboonkerd V, Mcleish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2001;62:1461-1469.
13. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomics patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
14. Hampel DJ, Sansome C, Sha M, Brodsky S, Lawson WE, Goligorsky MS. Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration. J Am Soc Nephrol. 2001;12:1026-1035.
15. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol. 2004;15:219-227.
16. Neuhoff N, Kaiser T, Wittke S, et al. Mass spectrometry for the detection of differentially expressed proteins: A comparison of SELDI and CE/MS technology. Rapid Commun Mass Spectrom. 2004;18:149-156.
17. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem. 2006;52(7):1223-1237.
18. Alagaratnam S, Mertens BJ, Dalebout JC, et al. Serum protein profiling in mice: Identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics. 2008;8(8):1552-1563.
19. Navare A, Zhou M, McDonald J, Noriega FG, Sullards MC, Fernandez FM. Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrixassisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 2008;22(7):997-1008.
20. Oetting WS, Rogers TB, Krick TP, Matas AJ, Ibrahim HN. Urinary beta2-microglobulin is associated with acute renal allograft rejection. Am J Kidney Dis. 2006;47(5):898-904.
21. Dai Y, Lv T, Wang K, Huang Y, Li D, Liu J. Detection of acute renal allograft rejection by analysis of renal tissue proteomics in rat models of renal transplantation. Saudi J Kidney Dis Transpl. 2008;19(6):952-959.
22. Wannemacher KM, Terskiy A, Bian S, Yadav PN, Li H, Howells RD. Purification and mass spectrometric analysis of the kappa opioid receptor. Brain Res. 2008;1230:13-26.
23. Yu M, Wang X, Du Y, et al. Comparative analysis of renal protein expression in spontaneously hypertensive rat. Clin Exp Hypertens. 2008;30(5):315-325.